COVID-19 Radiology findings

By Dr Deepu Changappa Cheriamane


Radiographic features

The primary findings of COVID-19 on chest radiograph and CT are thos
e of atypical pneumonia or organizing pneumonia.
However imaging has limited sensitivity for COVID-19, as up to 18% demonstrate normal chest radiographs or CT when mild or early in the disease course, but this decreases to 3% in severe disease. Bilateral and/or multilobar involvement is common.

The current recommendation of the vast majority of learned societies and professional radiological associations is that imaging should not be employed as a screening/diagnostic tool for COVID-19, but reserved for the evaluation of complications.

Plain radiograph

Although less sensitive than chest CT, chest radiography is typically the first-line imaging modality used for patients with suspected COVID-19. For ease of decontamination, use of portable radiography units is preferred.
Chest radiographs may be normal in early/mild disease. 
In those COVID-19 cases requiring hospitalization, 69% had an abnormal chest radiograph at the initial time of admission, and 80% had radiographic abnormalities sometime during hospitalization. Findings are most extensive about 10-12 days after symptom onset.
The most frequent findings are airspace opacities, whether described as consolidation or, less commonly, GGO. The distribution is most often bilateral, peripheral, and lower zone predominant 89.97. In contrast to parenchymal abnormalities, pleural effusion is rare (3%).


CT

The primary findings on CT in adults have been reported as 
ground-glass opacities (GGO): bilateral, subpleural, peripheral
crazy paving appearance (GGOs and inter-/intra-lobular septal thickening)
air space consolidation
bronchovascular thickening in the lesion
traction bronchiectasis
The ground-glass and/or consolidative opacities are usually bilateral, peripheral, and basal in distribution.

A retrospective study of 112 patients found 54% of asymptomatic patients had pneumonic changes on CT.

The following chest CT findings have been reported to have the highest discriminatory value (p<0.001).
peripheral distribution
ground-glass opacity
bronchovascular thickening (in lesions)

Atypical CT findings
These findings only seen in a small minority of patients should raise concern for superadded bacterial pneumonia or other diagnoses.

Temporal CT changes

Four stages on CT have been described
  • early/initial stage (0-4 days): normal CT or GGO only
  • halo half of patients have normal CT scans within two days of symptom onset
  • progressive stage (5-8 days): increased GGO and crazy paving appearance
  • peak stage (9-13 days): consolidation
  • absorption stage (>14 days): with an improvement in the disease course, "fibrous stripes" appear and the abnormalities resolve at one month and beyond
Pediatric CT
In a small study of five children that had been admitted to hospital with positive COVID-19 RT-PCR tests and who had CT chest performed, only three children had abnormalities. The main abnormality was bilateral patchy ground-glass opacities, similar to the appearances in adults, but less florid, and in all three cases the opacities resolved as they clinically recovered.
On 18 March 2020, the details of a much larger cohort of 171 children with confirmed COVID-19, and evaluated in a hospital setting was published as a letter in the New England Journal of Medicine. Ground-glass opacities were seen in one-third of the total, whereas almost 16% of children had no imaging features of pneumonia.

Ultrasound

Initial work on patients in China suggests that lung ultrasound may be useful in the evaluation of critically ill COVID-19 patients. The following patterns have been observed, tending to have a bilateral and posterobasal predominance:
  • multiple B-lines
  • ranging from focal to diffuse with spared areas
  • representing thickened subpleural interlobular septa
  • may also manifest as a light beam sign, an evanescent, broad-based vertical reverberation artifact arising from a regular pleural line
  • irregular, thickened pleural line with scattered discontinuities
  • subpleural consolidations
  • can be associated with a discrete, localized pleural effusion
  • relatively avascular with color flow Doppler interrogation
  • pneumonic consolidation typically associated with preservation of flow or hyperemia 65
  • alveolar consolidation
  • tissue-like appearance with dynamic and static air bronchograms
  • associated with severe, progressive disease 
  • restitution of aeration during recovery
  • reappearance of bilateral A-lines
 
Radiology report

The Radiological Society of North America (RSNA) has released a consensus statement endorsed by the Society of Thoracic Radiology and the American College of Radiology (ACR) that classifies the CT appearance of COVID-19 into four categories for standardized reporting language:

typical appearance

peripheral, bilateral, GGO +/- consolidation or visible intralobular lines (“crazy paving” pattern)
multifocal GGO of rounded morphology +/- consolidation or visible intralobular lines (“crazy paving” pattern)
reverse halo sign or other findings of organizing pneumonia

indeterminate appearance

absence of typical CT findings and the presence of
multifocal, diffuse, perihilar, or unilateral GGO +/- consolidation lacking a specific distribution and are non-rounded or non-peripheral
few very small GGO with a non-rounded and non-peripheral distribution

atypical appearance

absence of typical or indeterminate features and the presence of
isolated lobar or segmental consolidation without GGO
discrete small nodules (e.g. centrilobular, tree-in-bud) 
lung cavitation
smoother interlobular septal thickening with pleural effusion

negative for pneumonia:

 no CT features to suggest pneumonia, in particular, absent GGO and consolidation.

CO-RADS

In March 2020, the "COVID-19 standardized reporting working group" of the Dutch Association for Radiology (NVvR) proposed a CT scoring system for COVID-19. They called it CO-RADS (COVID-19 Reporting and Data System) to ensure CT reporting is uniform and replicable. This assigns a score of CO-RADS 1 to 5, dependent on the CT findings. In some cases a score of 0 or 6 may need to be assigned as an alternative. If the CT is uninterpretable then it is CO-RADS 0, and if there is a confirmed positive RT-PCR test then it is CO-RADS 6.
The first study investigating the use of CO-RADS found a reasonable level of interobserver variation, with a Fleiss' kappa score of 0.47 (cf. 0.24 for PI-RADS and 0.67 for Lung-RADS).

COVID-RADS

In April 2020, American radiologists based at the University of Southern California proposed the COVID-19 imaging reporting and data system (COVID-RADS), which has a confusingly similar name to CO-RADS (see above) 

Read more


COVID-19 Transmission

By Dr Deepu Changappa Cheriamane

Although originating from animals, COVID-19 is now considered to be an indirect zoonosis, as its transmission is now primarily human-to-human.
 It is predominantly transmitted in a similar way to the common cold, via contact with droplets of infected individuals' upper respiratory tract secretions, e.g. from sneezing or coughing.
A recent Bayesian regression model has found that aerosol and fomite transmission are plausible.
Orofecal spread was seen with the SARS epidemic, and although it remains unclear if SARS-CoV-2 can be transmitted in this way, there is some evidence for it.
Sexual transmission has not been seen in the field but remains possible, not least because the SARS-CoV-2 virus has been found in all bodily secretions including seminal and vaginal fluids.
It remains unclear if COVID-19 could be transmitted through a blood transfusion although no cases have yet be seen. Nevertheless, many national bodies have instituted controls to reduce the chance of this happening including advising that potential donors do not give blood until 28 days after recovering from COVID-19.
Cohort studies have been unable to rule out the possibility of vertical transmission, but it seems to be a rare event if it does occur. A large prospective cohort study of 427 pregnant women from all 194 birth units across the UK found that 5% of 265 live births were confirmed as COVID-19 on RT-PCR.

Read more

COVID 19 Pathophysiology

By Dr Deepu Changappa Cheriamane

The SARS-CoV-2 virus, like the closely-related MERS and SARS coronaviruses, effects its cellular entry via attachment of its virion spike protein (a.k.a. S protein) to the angiotensin-converting enzyme 2 (ACE2) receptor. This receptor is commonly found on alveolar cells of the lung epithelium, underlying the development of respiratory symptoms as the commonest presentation of COVID-19 50. It is thought that the mediation of the less common cardiovascular effects is also via the same ACE2 receptor, which is also commonly expressed on the cells of the cardiovascular system.

Read more

COVID 19 Pathology

By Dr Deepu Changappa Cheriamane

Etiology
On 9 January 2020, the World Health Organization (WHO) confirmed that SARS-CoV-2 was the cause of COVID-19 (2019-nCoV was the name of the virus at that time). It is one of the two strains of the SARS-CoV species known to cause human disease, the other being the original severe acute respiratory syndrome coronavirus (SARS-CoV), the cause of SARS. It is a member of the Betacoronavirus genus, one of the genera of the Coronaviridae family of viruses. Coronaviruses are enveloped single-stranded RNA viruses that are found in humans, mammals and birds. These viruses are responsible for pulmonary, hepatic, CNS, and intestinal disease. 
As with many human infections, SARS-CoV-2 is zoonotic. The closest animal coronavirus by genetic sequence is a bat coronavirus, and this is the likely ultimate origin of the virus. The disease can also be transmitted by snakes.
Six coronaviruses are known to cause human disease. Two are zoonoses: the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), both of which may sometimes be fatal. The remaining four viruses all cause the common cold. 



COVID19 Complications

By Dr Deepu Changappa Cheriamane

Complications of COVID 19

In one of the largest studies of hospitalized patients, reviewing 1,099 individuals across China, the admission rate to the intensive care unit (ICU) was 5%.
 In this same study, 6% of all patients required ventilation, whether invasive or non-invasive.
 
ICU patients tend to be older with more comorbidities.

Commonly reported sequelae are:

acute respiratory distress syndrome (ARDS): ~22.5% (range 17-29%)
acute thromboembolic disease
pulmonary embolism
deep vein thrombosis (DVT)

acute cardiac injury: 
elevated troponin levels
myocardial ischemia
cardiac arrest
myocarditis

CNS

delirium
viral encephalitis
diffuse leukoencephalopathy
microhemorrhage (seen in juxtacortical white matter and corpus callosum particularly of the splenium)
stroke: cryptogenic/ischemic
higher mortality and greater severity of stroke in context of COVID-19

secondary infections, e.g. bacterial pneumonia
sepsis
acute kidney injury (AKI)
coagulopathy
disseminated intravascular coagulation (DIC)
multiorgan failure

In a small subgroup of severe ICU cases:
secondary hemophagocytic lymphohistiocytosis (a cytokine storm syndrome)
Risk factors for pulmonary embolism

In a multivariate analysis, an elevated risk of developing PE was associated with:
obesity
elevated D-dimer
elevated CRP
rising D-dimer over time

Pediatric complications

In April 2020, reports started to appear of critically-ill children presenting with a multisystem inflammatory state which bore some resemblance to Kawasaki disease and toxic shock syndrome. Typically abdominal pain and other GI symptoms were present and often evidence of a myocarditis. The presentations necessitated ICU admission and fatalities have been reported.